StockData
Verastem, Inc. logo

Verastem, Inc. (VSTM) stock

VSTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 3/30
$7.41−0.29 (-3.77%)

Close on Nov 17, 2026Market cap $671.08MP/E –Yield –

Verastem cash

Cash and short-term investments held at the end of each period.

Verastem's cash was $136.40M at Jun 30, 2026. For fiscal 2025 it was $205.00M, up 130.9% from the year before. Over ten years it grew 6.4% a year on average. The highest annual figure on record is $249.70M in fiscal 2018.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$205.00M+130.9%
FY2024Dec 31, 2024$88.80M-35.8%
FY2023Dec 31, 2023$138.30M+57.3%
FY2022Dec 31, 2022$87.90M-12.4%
FY2021Dec 31, 2021$100.30M-32.0%
FY2020Dec 31, 2020$147.50M+32.5%
FY2019Dec 31, 2019$111.30M-55.4%
FY2018Dec 31, 2018$249.70M+188.0%
FY2017Dec 31, 2017$86.70M+7.2%
FY2016Dec 31, 2016$80.90M-26.6%
FY2015Dec 31, 2015$110.26M+19.0%
FY2014Dec 31, 2014$92.68M-8.5%
FY2013Dec 31, 2013$101.31M+79.1%
FY2012Dec 31, 2012$56.58M-6.9%
FY2011Dec 31, 2011$60.76M+1595.3%
FY2010Dec 31, 2010$3.58M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$136.40M-17.0%
Q1 FY2026Mar 31, 2026$181.70M+54.5%
Q4 FY2025Dec 31, 2025$205.00M+130.9%
Q3 FY2025Sep 30, 2025$137.70M+21.6%
Q2 FY2025Jun 30, 2025$164.30M+97.0%
Q1 FY2025Mar 31, 2025$117.60M-15.0%
Q4 FY2024Dec 31, 2024$88.80M-46.4%
Q3 FY2024Sep 30, 2024$113.20M-38.2%
Q1 FY2024Jun 30, 2024$83.40M-25.0%
Q4 FY2023Dec 31, 2023$138.30M+57.3%
Q3 FY2023Sep 30, 2023$165.70M+59.3%
Q2 FY2023Jun 30, 2023$183.10M+94.2%
Q1 FY2023Mar 31, 2023$111.20M+4.6%
Q4 FY2022Dec 31, 2022$87.90M-12.4%
Q3 FY2022Sep 30, 2022$104.00M+0.6%
Q2 FY2022Jun 30, 2022$94.30M-17.4%
Q1 FY2022Mar 31, 2022$106.30M-16.4%
Q4 FY2021Dec 31, 2021$100.30M-32.0%
Q3 FY2021Sep 30, 2021$103.40M-49.7%
Q2 FY2021Jun 30, 2021$114.10M-29.0%
Q1 FY2021Mar 31, 2021$127.10M-25.5%
Q4 FY2020Dec 31, 2020$147.50M+32.5%
Q3 FY2020Sep 30, 2020$205.70M+28.4%
Q2 FY2020Jun 30, 2020$160.80M-14.1%
Q1 FY2020Mar 31, 2020$170.70M-19.4%
Q4 FY2019Dec 31, 2019$111.30M-55.4%
Q3 FY2019Sep 30, 2019$160.20M+10.0%
Q2 FY2019Jun 30, 2019$187.30M+10.8%
Q1 FY2019Mar 31, 2019$211.70M+227.6%
Q4 FY2018Dec 31, 2018$249.70M+188.0%
Q3 FY2018Sep 30, 2018$145.60M+141.6%
Q2 FY2018Jun 30, 2018$169.10M+192.0%
Q1 FY2018Mar 31, 2018$64.62M-11.0%
Q4 FY2017Dec 31, 2017$86.70M+7.2%
Q3 FY2017Sep 30, 2017$60.26M-30.6%
Q2 FY2017Jun 30, 2017$57.92M-37.6%
Q1 FY2017Mar 31, 2017$72.57M–
Q4 FY2016Dec 31, 2016$80.90M–
Q3 FY2016Sep 30, 2016$86.88M–
Q2 FY2016Jun 30, 2016$92.87M–

More Verastem figures

See a number that looks wrong?